Identifying Antiphospholipid Antibodies Can Address Safety of JAK Inhibitors
Dr Bruce Rothschild discusses the importance of monitoring janus kinase inhibitor use in rheumatic diseases, the role of antiphospholipid antibodies for addressing safety, and more.